Semaglutide LinkPen – 10mg/3mL (300 Units) Prefilled Microdose Pen
The LinkPen delivers 10mg of Semaglutide in 3mL (300 units) of a preloaded, precision-filled pen designed for daily microdosing. This low-dose, high-frequency protocol supports smoother appetite control, improved glycemic regulation, and consistent weight loss—without the harsh side effects often seen in weekly injections.
This innovative format offers adjustable, low-impact dosing for both beginners and advanced users aiming to personalize their fat loss and metabolic health journey.
⚖️ Why Daily Microdosing?
- Gentle appetite suppression with less nausea and GI distress
- More stable blood sugar control throughout the day
- Reduced side effects vs. large weekly doses
- ⚡ Improved adherence thanks to flexible, comfortable daily injections
- Precision titration allows for gradual dose adjustments
Product Specs
| Compound | Total Content | Concentration |
|---|---|---|
| Semaglutide | 10mg per pen | 3.33mg/mL (300 units total) |
Dosing Protocol (Daily Microdosing)
- Pen Volume: 300 total units (3mL at 10mg total Semaglutide)
- Recommended Starting Dose: 4 units per day (≈133mcg)
- Titration: Increase by 2–4 units weekly based on response
- Typical Range: 4–10 units/day (≈133–333mcg)
- Pen Duration: 30–75 days depending on daily dose
- Injection Route: Subcutaneous (abdomen or thigh preferred)
Benefits of Semaglutide Microdosing
- Gradual and sustainable appetite suppression
- ♂️ Enhanced fat oxidation and insulin sensitivity
- Better focus and impulse control around food
- Clinical results in both obesity and type 2 diabetes management
- ⚡ Reduced likelihood of nausea, constipation, or injection fatigue
Stack Recommendations
- Fat Loss: Combine with Tesofensine, BAM15, or AOD-9604
- Insulin & Metabolic Health: Stack with Berberine or MOTS-c
- Muscle Retention: Pair with CJC-1295/Ipamorelin or low-dose Testosterone
Storage & Use
- Store unopened pens in refrigerator (2–8°C / 36–46°F)
- ️ After first use, can be stored at room temperature for up to 30 days
- Subcutaneous injection with fine insulin syringe or auto-pen tip
⚠️ Warnings & Considerations
- ⚠️ Not for individuals with a history of medullary thyroid carcinoma or MEN2
- May cause mild nausea, especially during dose escalation
- Do not combine with other GLP-1 agonists without medical guidance
- Not for use by individuals under the age of 21
Legal Disclaimer
This product is for research and educational purposes only. It is not approved by the FDA for the diagnosis, treatment, or prevention of any disease. All information provided is for informational use only. By purchasing, you agree to use this product in accordance with all applicable laws and assume full responsibility for its use.
